Skip to main content
Clinical Trials/IRCT20200413047056N1
IRCT20200413047056N1
Recruiting
Phase 3

Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in improving the condition of patients with COVID-19: A randomized clinical trial

Birjand University of Medical Sciences0 sites15 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Birjand University of Medical Sciences
Enrollment
15
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • RT\-PCR Confirm the infection in the throat swab or sputum or lower respiratory tract samples.
  • Sign the Informed Consent Form on a voluntary basis.
  • Meet any of the following criteria for severe or critical ill conditions:Respiratory rate \>\=30/min; orRest SPO2\<\=90%; orPaO2/FiO2\<\=300mmHg; orRespiratory failure and needs mechanical ventilation; orMultiple organ failure and needs ICU monitoring

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials